MATTHEW HILGART: Open Payments
NPI 1821756347 · CLEARWATER, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,978 in 240 payments from 35 companies in 2025. Trend: 2023 $4,249 · 2024 $4,395 · 2025 $4,978
Food & beverage: $4,978
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 20 | $807 |
| ABBVIE INC. | 19 | $362 |
| Corcept Therapeutics | 12 | $283 |
| PFIZER INC. | 15 | $281 |
| Novo Nordisk Inc | 13 | $267 |
| Kowa Pharmaceuticals America, Inc. | 31 | $228 |
| GlaxoSmithKline, LLC. | 10 | $213 |
| Otsuka America Pharmaceutical, Inc. | 13 | $206 |
| UCB, Inc. | 8 | $205 |
| Indivior Inc. | 10 | $203 |
Products named: Auvelity, Korlym, REXULTI, NURTEC ODT, ZORYVE, TRELEGY ELLIPTA, Bimzelx, SUBLOCADE.
Industry payments across FL — which companies pay providers there.
